Literature DB >> 11791458

Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.

H Schulze-Koops1, P E Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11791458     DOI： 10.1159/000060506

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN： 1422-2132


× No keyword cloud information.
  10 in total

1.  An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques.

Authors:  Jennifer A Schwartz; Ilia Prado; Johnathan Misamore; Deborah Weiss; Jesse Francis; Ranajit Pal; Maria Huaman; Anthony Cristillo; George K Lewis; Robert C Gallo; Anthony L DeVico; Timothy R Fouts
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

Review 2.  The role of the T cell in autoimmune inflammation.

Authors:  Alla Skapenko; Jan Leipe; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

3.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.

Authors:  D Pohlers; K Nissler; O Frey; J Simon; P K Petrow; R W Kinne; R Bräuer
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 4.  Cell therapy for autoimmune diseases: does it have a future?

Authors:  A Radbruch; A Thiel
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

5.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

6.  Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells.

Authors:  K Pinz; H Liu; M Golightly; A Jares; F Lan; G W Zieve; N Hagag; M Schuster; A E Firor; X Jiang; Y Ma
Journal:  Leukemia       Date:  2015-11-03       Impact factor: 11.528

7.  CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis.

Authors:  Elmieke P J Boot; Gerben A Koning; Gert Storm; Josée P A Wagenaar-Hilbers; Willem van Eden; Linda A Everse; Marca H M Wauben
Journal:  Arthritis Res Ther       Date:  2005-03-21       Impact factor: 5.156

8.  Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.

Authors:  Elisa Claeys; Eva Pauwels; Stephanie Humblet-Baron; Becky Provinciael; Dominique Schols; Mark Waer; Ben Sprangers; Kurt Vermeire
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

9.  Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain.

Authors:  Lisa M McGinley; Kevin S Chen; Shayna N Mason; Diana M Rigan; Jacquelin F Kwentus; John M Hayes; Emily D Glass; Evan L Reynolds; Geoffrey G Murphy; Eva L Feldman
Journal:  Clin Transl Med       Date:  2022-09

Review 10.  Leukotrienes, mast cells, and T cells.

Authors:  Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2003-10-15       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.